Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124572) titled 'Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy' on Aug. 6.
Study Type: Observational
Primary Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Condition:
Thyroid Associated Ophthalmopathy
Intervention:
Other: Imaging and ocular examinations
Recruitment Status: Recruiting
Date of First Enrollment: October 1, 2022
Target Sample Size: 500
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07124572
Published by HT Digital Content Services with permission from Health Daily Digest....